Shareholders of Lot78 Appoint Ollie Amhurst as President and CEO
NEW YORK, Feb. 20, 2013 /PRNewswire/ -- Lot78, Inc. (the "Company"), is pleased to announce the appointment of Mr. Ollie Amhurst as President and CEO. Mr. Amhurst is formerly the head of European sales for Giorgio Armani S.P.A. ("Armani") and is the founder of Lot78.
Closely working with the Italian brand Armani and being a key member in the success of the brand's growth inspired the idea of 'Lot78'. The unparalleled quality and craftsmanship of Armani, acted as key drivers for sales strategy and product popularity, which now underline the key strengths and strategy of Lot78.
Further to his appointment, Mr. Amhurst stated, 'this is a very exciting time for lot78. We have managed to build a strong foundation over the past few years in order to build aggressively as a brand into the global market by opening stand alone stores, further increasing our wholesale division and increasing brand exposure through PR and marketing.'
About Lot78, Inc.
Lot78, Inc. is a trend-setting leader in the design, marketing, distribution and sale of urban apparel – retailing under the brand name "Lot78" in six continents, including: North America, Europe, Asia, Australia, Africa and South America. Lot78 has been featured in US Weekly, Elle Magazine, Financial Times, Harrods Magazine, The London Evening Standard, and Grazia Magazine as an emerging global brand.
Lot78, Inc. is quoted on the OTC Bulletin Board in the United States of America under the symbol LOTE.OB. Fore more information, please visit www.lot78.com
Cautionary Note Regarding Forward-Looking Statements
The following discussion, in addition to the other information contained in this communication, should be considered carefully in evaluating our prospects. This communication (including without limitation the following factors that may affect operating results) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended ("Exchange Act") regarding us and our business, financial condition, results of operations and prospects. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this communication. Additionally, statements concerning future matters such as revenue projections, projected profitability, growth strategies, possible changes in legislation and other statements regarding matters that are not historical are forward-looking statements.
Forward-looking statements in this communication reflect the good faith judgment of our management and the statements are based on facts and factors as we currently know them. Forward-looking statements are subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, but are not limited to, those discussed in this communication. Readers are urged not to place undue reliance on these forward-looking statements which speak only as of the date of this communication. We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this communication.
SOURCE Lot78, Inc.
More by this Source
Lot78 Launches Distribution with Bloomingdale's US
Sep 04, 2013, 10:05 ET
Lot78 Signs Exclusive Agency Agreement with Major European Distributor: Fourmarketing
Aug 23, 2013, 09:30 ET
Lot78 raises $825k in first round of private placements and announces new CFO
Aug 14, 2013, 09:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.